Engineering Predictability into Complex Biologics
Kovi Life Sciences is a specialized biotechnology engineering partner dedicated to de-risking technology transfer, upstream & downstream optimization, and commercial scale-up for recombinant therapeutics and complex proteins.
To bridge the divide between laboratory innovation and commercial manufacturing — delivering validated, reproducible bioprocesses that make life-saving therapeutics accessible worldwide.”
The Three Pillars of Kovi
How our unified engineering framework ensures seamless execution from early construct validation through commercial production.
Innovate
We leverage Quality by Design (QbD) and Design of Experiments (DoE) modeling to optimize upstream expression titers and develop breakthrough purification sequences.
Integrate
Single-partner continuity from clone design to full-scale Tech Transfer Master Plans (TTMP) and complete eCTD Module 3 regulatory dossiers.
Impact
Accelerating therapeutic market readiness, reducing cost-of-goods (COGs), and enabling global accessibility for critical medicines.
Our 5-Stage Engineering Framework
A rigorous Quality by Design (QbD) process that minimizes risk and guarantees process reproducibility across receiving manufacturing sites.
Construct & Feasibility
Clone screening, expression vector validation, and initial titer proof-of-concept.
Upstream DoE
Media formulation, feed strategy, and high cell density fermentation kinetics.
Downstream Recovery
Chromatography capture, refolding optimization, and viral clearance filtration.
Analytical Validation
ICH method validation, purity profile verification, and stability testing.
Commercial Transfer
TTMP execution, facility fit assessment, and commercial validation batches.
Engineered for Biologics Excellence
Specialized in Biologics Technology Transfer
Our entire practice is built around the challenges of complex biologics — not a side offering within a larger organization.
Expertise Across Microbial & Mammalian Platforms
We operate across both fermentation-based and mammalian cell culture systems, giving clients broader molecule coverage.
Focus on Scalability & GMP Readiness
Every process we develop is designed with commercial-scale and regulatory compliance in mind from day one.
Integrated Support: Clone → Process → Scale → Commercial
A single partner for the full development journey — reducing handoff risk and keeping timelines on track.
Ideal Partner for Biosimilars, CDMOs & Biotech Startups
Whether you're developing a biosimilar or building a new biologics program, we adapt to your stage and scale.
Ready to Accelerate Your Biologics Program?
Schedule a technical consultation with our process development and technology transfer specialists.